Details for New Drug Application (NDA): 050802
✉ Email this page to a colleague
The generic ingredient in ZIANA is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
Summary for 050802
Tradename: | ZIANA |
Applicant: | Bausch |
Ingredient: | clindamycin phosphate; tretinoin |
Patents: | 0 |
Pharmacology for NDA: 050802
Physiological Effect | Decreased Sebaceous Gland Activity |
Suppliers and Packaging for NDA: 050802
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZIANA | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050802 | NDA AUTHORIZED GENERIC | Oceanside Pharmaceuticals | 68682-300 | 68682-300-30 | 1 TUBE in 1 CARTON (68682-300-30) / 30 g in 1 TUBE |
ZIANA | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050802 | NDA AUTHORIZED GENERIC | Oceanside Pharmaceuticals | 68682-300 | 68682-300-60 | 1 TUBE in 1 CARTON (68682-300-60) / 60 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TOPICAL | Strength | 1.2%;0.025% | ||||
Approval Date: | Nov 7, 2006 | TE: | AB1 | RLD: | Yes |
Expired US Patents for NDA 050802
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | ZIANA | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050802-001 | Nov 7, 2006 | ⤷ Subscribe | ⤷ Subscribe |
Bausch | ZIANA | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050802-001 | Nov 7, 2006 | ⤷ Subscribe | ⤷ Subscribe |
Bausch | ZIANA | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050802-001 | Nov 7, 2006 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription